SGO Issues July 11, 2013
SGO Breast Certificate completes first pilot programs
SGO works for Medicare physician payment reform
Annual Meeting abstract submission opens July 22
Early registration deadline for Allied Workshop July 19
Updated Gynecologic Oncology author guidelines
Upgrade your SGO Membership
Women’s Cancer News on Wednesdays
Register now for SGO State of the Art 2013
On Your Side: The Gynecologic Cancer Care Team
In the News
On June 30, one-year pilot programs for SGO Breast Certificate Training were completed at Hope Women’s Cancer Centers in Asheville, NC, and at Women & Infants Hospital in Providence, RI. The programs were initiatives developed by SGO’s Breast Committee, which is chaired by James Orr, Jr., MD, FACOG, FACS, Past SGO President and Medical Director of Florida Gynecologic Oncology & Regional Cancer Center in Fort Myers, FL.
The program includes comprehensive breast-specific training in the areas of clinical evaluation and assessment; breast and diagnostic imaging; breast surgery; plastic and reconstructive surgery; pathology; genetics; medical oncology; radiation oncology; community service and outreach; research; survivorship, rehabilitation, and supportive/palliative care. Two fellows will receive a certificate from SGO stating that they have completed a one-year comprehensive Breast Certificate Training Program in gynecologic oncology later this summer.
The Hope Women’s Cancer Centers program was conducted under the direction of gynecologic oncologist David J. Hetzel, MD, FACOG, FACS; and the Women & Infants Hospital program was headed by Skip Granai, MD, FACOG, FACS, Director of the Program in Women’s Oncology.
The breast certificate training through SGO is part of a multidisciplinary approach to women’s cancer care. Currently there is no board certification in the management of breast disease.
“We know (the number of) procedures it takes…to learn to become proficient in most surgical cases is somewhere around 50,” said Dr. Orr. “We say you’ve got to have this specific training before you are eligible to receive a certificate. You have to have these numbers.”
Dr. Orr added that obtaining such a certificate “rounds out” the training that gynecologic oncologists have already received for women’s cancer care.
“It clearly takes the gynecologic oncologist who is already proficient in a wide array of surgical procedures, understands the role of chemotherapy, and recognizes the important clinical aspects and role of radiation therapy. Gynecologic oncologists are in a perfect position to modify their use of their existing ‘honed’ clinical tools and modify those skills to evaluate and manage breast malignancies,” he said. “It makes us whole as it relates to the care of women with cancers that are unique to them. I truly believe that this program will absolutely improve women’s heath care!”
Dr. Granai said that Women & Infants Hospital has incorporated breast disease training in its gynecologic oncology fellowship program for nearly 15 years. “Basically having the recognition or the acknowledgment of the SGO as having had a certain quality of training is a very important thing,” he added. “That is a powerful statement to credential committees, to universities, and eventually it should be to society. I think women will begin to look and say, ‘Does this person have a training that is recognized by the SGO?’ and that will be an important thing that shifts health care for the better.”
In addition to Women & Infants Hospital and Hope Women’s Cancer Centers, Dr. Orr noted that at least two more institutions have expressed an interest in participating in SGO’s Breast Certificate Training Program. For more information on participating in this program, contact SGO Education at email@example.com.
On July 9, SGO president Barbara A. Goff, MD, submitted a letter to Congressman Fred Upton (MI-6th District), Chairman of the Energy & Commerce Committee, and Congressman Joe Pitts (PA-16th District), Chairman of the Energy & Commerce Health Subcommittee, in an effort to convince Congress to repeal the Medicare Sustainable Growth Rate (SGR) formula and enact meaningful Medicare physician payment reform.
The letter—the fourth in a series of letters sent to the congressional committees regarding SGR—includes detailed responses to 13 questions that the Committee and Subcommittee posed to medical societies at the time that the legislative framework was released on June 28. SGO also responded to a request for input from the Senate Finance Committee regarding the future of the SGR.
Abstract submission for the 45th SGO Annual Meeting on Women’s Cancer in Tampa, FL, will open Monday, July 22, 2013, and close Wednesday, Sept. 18, 2013. Research will be peer reviewed by the 2014 Annual Meeting Program Committee and accepted science will be announced in November 2013. SGO encourages all medical professionals who are a part of a women’s cancer care team to submit abstracts and surgical films for consideration in the 2014 scientific program.
Additional information on research considerations and categories are available on the Request for Abstracts webpage.
July 19 is the early bird registration deadline for SGO’s Allied Health Professionals Workshop: Optimizing Endometrial Cancer Care, to be held Saturday, Oct. 12, 2013, in Nashville, TN. This educational workshop is open to advanced practice providers or nurse clinicians who want to learn more about endometrial cancer care. SGO members pay only $99.00 when registering before July 19, and non-SGO members pay $125.00.
Allied members in their first year of membership can receive a 50 percent discount off an SGO meeting rate. Eligible members interested in attending the allied workshop should enter promo code NEWMEM-50 during registration to pay only $49.50 when registering before the July 19 deadline. Visit the Allied Workshop page for more information on the workshop’s educational sessions, hotel/travel arrangements and registration methods.
In order to reduce the time that authors need to spend formatting the reference style in their submitted manuscripts while maximizing the discoverability of articles, Elsevier, publisher of Gynecologic Oncology, has updated its Guide for Authors with the following instructions:
Discoverability of research and high quality peer review are ensured by online links to the sources cited. In order to allow us to create links within ScienceDirect and to abstracting and indexing services, such as Scopus, CrossRef or PubMed, please ensure that data provided in the references are correct. Please note that incorrect surnames, journal/book titles, publication year and pagination may prevent the link creation. When copying references, please be careful as they may already contain an error.
There are no strict requirements on reference formatting at submission. References can be in any style or format as long as the style is consistent. Author(s) name(s), journal title/book title, chapter title/article title, year of publication, volume and issue/book chapter and the pagination must be present. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof stage. Note that incorrect or missing data will be highlighted at proof stage for the author to correct.
Contact firstname.lastname@example.org to find out if you are ready for the next level of SGO Membership. Applications are due July 31.
- Those who passed their ABOG Gynecologic Oncology Boards are eligible for Full Membership
- Graduating Fellow-in-Training Members should apply for Candidate Membership
- Newly matched Fellows can apply for Fellow-in-Training Membership
SGO Women’s Cancer News is now being sent to members every Wednesday. Be sure to add email@example.com to your e-mail’s safe senders list to receive your copy. To view the Women’s Cancer News archive, click here.
State of the Art Conference/International Society for the Study of Trophoblastic Diseases (ISSTD) World Congress XVII: Sept. 20-23, 2013, in Chicago, IL. Register here.
Share the SGO video, “On Your Side: The Gynecologic Cancer Care Team,” with patients and others who want to learn more about the subspecialty of gynecologic oncology.
Many docs don’t follow HPV/Pap test guidelines (July 9, 2013)
Roche’s bid to expand HPV test could edge out Pap (July 9, 2013)
Annual cervical cancer screenings may cause more harm than good (July 9, 2013)
Antiviral therapy may trigger some genetic variants of cervical cancer (July 9, 2013)
Study: Cancer patients less likely to get Alzheimer’s (July 10, 2013)